Opaleye Management as of Dec. 31, 2020
Portfolio Holdings for Opaleye Management
Opaleye Management holds 59 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ocular Therapeutix (OCUL) | 17.6 | $135M | 6.5M | 20.70 | |
| Protara Therapeutics Com Stk (TARA) | 8.1 | $62M | 2.6M | 24.21 | |
| Eidos Therapeutics | 5.4 | $42M | 316k | 131.58 | |
| Eton Pharmaceuticals (ETON) | 4.3 | $33M | 4.0M | 8.13 | |
| Codexis (CDXS) | 4.0 | $31M | 1.4M | 21.83 | |
| Cardiff Oncology (CRDF) | 3.9 | $30M | 1.7M | 17.99 | |
| Tracon Pharmaceuticals Com New | 3.8 | $30M | 2.5M | 11.70 | |
| Chemocentryx | 2.8 | $22M | 350k | 61.92 | |
| Acutus Medical (AFIB) | 2.8 | $22M | 750k | 28.81 | |
| Harrow Health (HROW) | 2.7 | $21M | 3.1M | 6.86 | |
| Tg Therapeutics (TGTX) | 2.6 | $20M | 388k | 52.02 | |
| Xoma Corp Del Com New (XOMA) | 2.6 | $20M | 455k | 44.13 | |
| Neoleukin Therapeutics | 2.6 | $20M | 1.4M | 14.10 | |
| Chimerix (CMRX) | 2.5 | $19M | 4.0M | 4.83 | |
| Celldex Therapeutics Com New (CLDX) | 2.3 | $17M | 992k | 17.52 | |
| Stereotaxis Com New (STXS) | 2.0 | $15M | 3.0M | 5.09 | |
| Deciphera Pharmaceuticals | 1.7 | $13M | 222k | 57.07 | |
| Fortress Biotech | 1.6 | $12M | 3.9M | 3.17 | |
| Cytokinetics Com New (CYTK) | 1.6 | $12M | 583k | 20.78 | |
| Myovant Sciences | 1.4 | $11M | 683k | 15.37 | |
| Lumos Pharma | 1.3 | $10M | 281k | 35.71 | |
| Seres Therapeutics | 1.3 | $9.8M | 335k | 29.24 | |
| Biohaven Pharmaceutical Holding | 1.3 | $9.8M | 114k | 85.71 | |
| Kalvista Pharmaceuticals (KALV) | 1.2 | $8.9M | 470k | 18.99 | |
| Vaxcyte (PCVX) | 1.2 | $8.9M | 335k | 26.57 | |
| Macrogenics (MGNX) | 1.1 | $8.5M | 371k | 22.86 | |
| Fs Dev Corp Com Cl A | 1.0 | $7.7M | 704k | 11.00 | |
| Protagonist Therapeutics (PTGX) | 0.9 | $7.0M | 260k | 27.00 | |
| Sutro Biopharma (STRO) | 0.9 | $7.0M | 322k | 21.71 | |
| Cerecor | 0.9 | $6.9M | 2.6M | 2.64 | |
| Tricida | 0.9 | $6.8M | 959k | 7.05 | |
| Infinity Pharmaceuticals (INFIQ) | 0.9 | $6.7M | 3.2M | 2.12 | |
| Five Prime Therapeutics | 0.8 | $6.5M | 382k | 17.01 | |
| Adamas Pharmaceuticals | 0.8 | $6.4M | 1.5M | 4.33 | |
| Merus N V (MRUS) | 0.8 | $6.2M | 353k | 17.53 | |
| Sio Gene Therapies | 0.7 | $5.6M | 2.0M | 2.78 | |
| Tela Bio (TELA) | 0.7 | $5.5M | 365k | 15.04 | |
| Fibrogen | 0.7 | $5.5M | 147k | 37.09 | |
| Verastem | 0.6 | $4.8M | 2.3M | 2.05 | |
| Mei Pharma Com New | 0.5 | $4.1M | 1.6M | 2.64 | |
| Kiniksa Pharmaceuticals Com Cl A | 0.5 | $4.0M | 224k | 17.67 | |
| Kezar Life Sciences | 0.5 | $3.7M | 708k | 5.22 | |
| Aptose Biosciences Com New | 0.5 | $3.5M | 800k | 4.38 | |
| Praxis Precision Medicines I | 0.5 | $3.5M | 63k | 55.02 | |
| Rhythm Pharmaceuticals (RYTM) | 0.4 | $3.4M | 115k | 29.73 | |
| Edap Tms Sa Sponsored Adr (EDAP) | 0.4 | $3.4M | 658k | 5.17 | |
| Essa Pharma Com New (EPIX) | 0.4 | $3.4M | 284k | 11.93 | |
| Concert Pharmaceuticals I equity | 0.4 | $3.2M | 254k | 12.64 | |
| Contrafect Corp Com New | 0.3 | $2.2M | 440k | 5.05 | |
| Optinose | 0.2 | $1.8M | 435k | 4.14 | |
| Sierra Oncology Com New | 0.2 | $1.2M | 75k | 16.03 | |
| Amarin Corp Sponsored Adr New | 0.1 | $1.1M | 225k | 4.89 | |
| Fulcrum Therapeutics (FULC) | 0.1 | $1.0M | 88k | 11.71 | |
| Catalyst Biosciences Com New | 0.1 | $939k | 149k | 6.31 | |
| Akouos | 0.1 | $901k | 46k | 19.82 | |
| Catabasis Pharmaceuticals Com New | 0.1 | $402k | 188k | 2.14 | |
| Magenta Therapeutics | 0.0 | $375k | 48k | 7.84 | |
| Aveo Biosciences Com New | 0.0 | $339k | 59k | 5.77 | |
| Biolinerx Sponsored Ads | 0.0 | $42k | 17k | 2.52 |
